Currents status of radiotracers for breast cancer imaging in PET
Radiolabeled molecules have become valuable tools in the diagnosis, monitoring, and treatment of cancer, particularly breast cancer. Through the use of radiotracers, clinicians can target specific tumor cells, assess microenvironments, and identify metastases. These radiopharmaceuticals, based on ra...
Main Authors: | Chloé Jean, Stéphane Roux, Abdelilah Aziz, Maxence Mocquery-corre, Rana Bazzi, Yacine Merrouche, Stéphane Dedieu, Nicolas Etique, Dimitri Papathanassiou, Jérôme Devy |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-03-01
|
Series: | Translational Oncology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S193652332500035X |
Similar Items
-
Computational Chemistry for the Identification of Lead Compounds for Radiotracer Development
by: Chia-Ju Hsieh, et al.
Published: (2023-02-01) -
Radiotracer Innovations in Breast Cancer Imaging: A Review of Recent Progress
by: Mohamad Haidar, et al.
Published: (2024-09-01) -
PET Radiotracers for CNS-Adrenergic Receptors: Developments and Perspectives
by: Santosh Reddy Alluri, et al.
Published: (2020-09-01) -
PET Neuroimaging of Alzheimer's Disease: Radiotracers and Their Utility in Clinical Research
by: Weiqi Bao, et al.
Published: (2021-05-01) -
Fluorine-18 Labelled Radioligands for PET Imaging of Cyclooxygenase-2
by: Jatinder Kaur, et al.
Published: (2022-06-01)